Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050023/S215

Ilivia 7 VR-T DX DF-1 ProMRI Ilivia 7 VR-T DF-1 ProMRI Ilivia 7 VR-T DF4 ProMRI Intica 7 VR-T DX DF-1 ProMRI Intica 7 VR

Biotronik, Inc. · Decision date Oct 13, 2026

MEDTECHLEDGER EXPLANATIONP050023/S215

What did the FDA decide?

The FDA recorded a 30-day notice decision coded OK30 on 2026-10-13 for PMA supplement P050023/S215 from Biotronik, Inc. The supplement covers a change to the rework process for manufacturing the housing of pulse generators and ICDs. The listed products are Ilivia 7 VR-T DX DF-1 ProMRI, Ilivia 7 VR-T DF-1 ProMRI, Ilivia 7 VR-T DF4 ProMRI, Intica 7 VR-T DX DF-1 ProMRI and Intica 7 VR-T, all implantable dual-chamber defibrillators under product code MRM in the cardiovascular specialty.

The supplement reason is recorded as a process change involving manufacturer, sterilizer, packager or supplier. This entry documents a manufacturing-process modification for the device housing; it is not an approval of a new device or of the full system, and the source gives no detail on the prior versus revised rework steps, validation data or housing materials. No supporting documents were included, so the technical basis for OK30 cannot be assessed from this record.

Whether the revised rework process affects housing integrity or device performance is not stated in the available data and would require the underlying FDA filing.

FDA approval order statement

a change to the rework process for the manufacturing of the housing for pulse generators and ICDS
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 13, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P050023/S215
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
OK30
Decision date
Oct 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P050023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050023 · Original PMA

    TUPOS LV/ATX & KRONOS LV-T CRT-D & COROX OWT STEROID LV PACING LEAD

  2. P050023/S211 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, R

  3. P050023/S215 received

    Application receipt date recorded by FDA.

  4. P050023/S204 · Related supplement

    Ilivia 7 VR-T DX 404624; Intica 7 VR-T DX 404633; Intica 5 VR-T DX 404688; Ilivia 7 VR-T 404625; Intica 7 VR-T 404634; I

  5. P050023/S214 · Related supplement

    Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, Rivacor Sky HF-T QP, Riva

  6. P050023/S213 · Related supplement

    Acticor Sky HF-T 481986; Rivacor Sky HF-T 481991; Rivacor Rise HF-T 482017; Rivacor Aura HF-T 482013; Acticor Sky HF-T Q

  7. P050023/S215 · FDA decision

    30-Day Notice

  8. P050023/S216 · Related supplement

    Ilivia 7 VRT DX, Intica 7 VRT DX, Intica 5 VRT DX, Ilivia 7 VRT, Intica 7 VRT, Intica 5 VRT, Inlexa 7 VRT, Inlexa 7 VRT

Timeline entries are records held by MedtechLedger for P050023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050023

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records